PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanoma

JCI Insight. 2022 Oct 24;7(20):e165688. doi: 10.1172/jci.insight.165688.
No abstract available

Publication types

  • Published Erratum

MeSH terms

  • Humans
  • Melanoma*
  • Membrane Proteins
  • Programmed Cell Death 1 Receptor
  • Thiolester Hydrolases

Substances

  • Programmed Cell Death 1 Receptor
  • PPT1 protein, human
  • Membrane Proteins
  • Thiolester Hydrolases